Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2016 | Pages:
38 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016', provides an overview of the Circassia Pharmaceuticals Plc's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Circassia Pharmaceuticals Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Circassia Pharmaceuticals Plc - The report provides overview of Circassia Pharmaceuticals Plc including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Circassia Pharmaceuticals Plc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Circassia Pharmaceuticals Plc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Circassia Pharmaceuticals Plc's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Circassia Pharmaceuticals Plc - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Circassia Pharmaceuticals Plc's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Circassia Pharmaceuticals Plc Snapshot 5 Circassia Pharmaceuticals Plc Overview 5 Key Information 5 Key Facts 5 Circassia Pharmaceuticals Plc - Research and Development Overview 6 Key Therapeutic Areas 6 Circassia Pharmaceuticals Plc - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Circassia Pharmaceuticals Plc - Pipeline Products Glance 12 Circassia Pharmaceuticals Plc - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Circassia Pharmaceuticals Plc - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Circassia Pharmaceuticals Plc - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Circassia Pharmaceuticals Plc - Drug Profiles 16 Vaccine for Grass-Induced Rhinoconjunctivitis and Asthma 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 glycopyrronium bromide 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Vaccine for Asthma and Ragweed-Induced Rhinoconjunctivitis 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Vaccine for Birch Pollen Allergy 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Vaccine for House Dust Mite Induced Allergic Rhinoconjunctivitis 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 (fluticasone propionate + glycopyrronium bromide + salmeterol xinafoate) 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Vaccine for Japanese Cedar Pollen Allergy 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 (Inhaled Corticosteroid + Long-acting Muscarinic Antagonist) 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 (Long Acting Beta-2 Agonist + Long Acting Muscarinic Receptor Antagonist) 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Vaccine for Alternaria Allergy 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Circassia Pharmaceuticals Plc - Pipeline Analysis 28 Circassia Pharmaceuticals Plc - Pipeline Products by Target 28 Circassia Pharmaceuticals Plc - Pipeline Products by Route of Administration 29 Circassia Pharmaceuticals Plc - Pipeline Products by Molecule Type 30 Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action 31 Circassia Pharmaceuticals Plc - Recent Pipeline Updates 32 Circassia Pharmaceuticals Plc - Dormant Projects 35 Circassia Pharmaceuticals Plc - Locations And Subsidiaries 36 Head Office 36 Other Locations & Subsidiaries 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 37 Disclaimer 38
List of Tables
Circassia Pharmaceuticals Plc, Key Information 5 Circassia Pharmaceuticals Plc, Key Facts 5 Circassia Pharmaceuticals Plc - Pipeline by Indication, 2016 8 Circassia Pharmaceuticals Plc - Pipeline by Stage of Development, 2016 9 Circassia Pharmaceuticals Plc - Monotherapy Products in Pipeline, 2016 10 Circassia Pharmaceuticals Plc - Combination Treatment Modalities in Pipeline, 2016 11 Circassia Pharmaceuticals Plc - Phase III, 2016 12 Circassia Pharmaceuticals Plc - Phase II, 2016 13 Circassia Pharmaceuticals Plc - Phase I, 2016 14 Circassia Pharmaceuticals Plc - Preclinical, 2016 15 Circassia Pharmaceuticals Plc - Pipeline by Target, 2016 28 Circassia Pharmaceuticals Plc - Pipeline by Route of Administration, 2016 29 Circassia Pharmaceuticals Plc - Pipeline by Molecule Type, 2016 30 Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action, 2016 31 Circassia Pharmaceuticals Plc - Recent Pipeline Updates, 2016 32 Circassia Pharmaceuticals Plc - Dormant Developmental Projects,2016 35 Circassia Pharmaceuticals Plc, Subsidiaries 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
